Vor Biopharma Inc.

US$19.88As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VORHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (48.81%)
Div yield —
ROE —
Biotechnology
Beta (5Y) 1.83
PE TTM 0.652
TSR TTM (17.54%)
Mkt cap US$1.221B
ROIC —
SE Grade™
Value
Quality
Moat
Consensus
Reference
$21
7.53%
(87.08%)
Hold 1|6|8|0|5
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.22
0.23
0.23
0.24
11.26%
1.82%
1.13%
14.47%
Revenue$M
51.05
49.88
49.27
50.15
0.81%
1.25%
(0.66%)
(2.44%)
Peers (US$1.221B)
Cap (US$)
PE
1.227B
—
1.225B
10.77x
1.214B
—
Capital
TTM
5Y
10Y
Leveragex
4.207
(1.098)
(0.950)
EBIT/Intx
0.116
0.332
0.290
Own earn%
61.38
(14.32)
(5.60)
Sh yield%
10.60
34.27
31.51
Owners
Insiders/Inst%
5.44
58.76
Short interest%
1.06
SBC / revenue%
4.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
23
Op margin range%
7–21
$1 testx
—
Incr. ROIC%
6